U.S. Recommends Pausing Use of J&J COVID Vaccine over Rare Blood Clots

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six recipients developed a rare disorder involving blood clots, in a fresh setback to global efforts to tackle the pandemic. The move comes …

from News – Insurance Journal https://ift.tt/32bO44U